Work

Lymphocyte Kinetics and Outcomes of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma With Out of Specification Products

Year: 2025

Type: article

Source: American Journal of Hematology

DOI: 10.1002/ajh.70001

Authors: Sarah Dingli, Paul Rothweiler, Moritz Binder, Joselle Cook, Morie A. Gertz, Suzanne Hayman, Prashant Kapoor, Taxiarchis Kourelis, Shaji K. Kumar, Mustaqeem Siddiqui, Rahma Warsame, Yi Lin, Arthur G. Erdman, David Dingli

Institutions: University of Minnesota, Mayo Clinic

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Amgen, Bristol-Myers Squibb, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Gilead Sciences, Alexion Pharmaceuticals, Alnylam Pharmaceuticals, Regeneron Pharmaceuticals, Prothena, BeiGene, Omeros Corporation, Apellis Pharmaceuticals, Moderna, Genentech, Pharmacyclics, National Cancer Institute

Award: G555916542

OpenAlex ID: W4412422753

FWCI: 1.081

Cites: 10

Cited by: 3

Related to: 10